Galmed Pharmaceuticals Ltd. cotiza a 3.16 USD y tiene una capitalización bursátil de $3M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Eocene Ltd. a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications. The company develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in a Phase III study for oral treatment for non-alcoholic steato-hep…
| Periodo | 2026-09 | 2026-07 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | $-2.86 | $-2.32 | $-7.36 | $-2.64 |
| Estimado | $-3.12 | $-3.04 | $-4.08 | $-4.32 |
| Sorpresa | +8.3% | +23.7% | -80.4% | +38.9% |
| Métrica | EOCN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -65.3% | -40.4% | -24.9% |
| ROA | -55.3% | -32.0% | -23.3% |
| Current Ratio | 6.55 | 2.84 | +3.71 |
| Debt / Equity | — | 0.28 | — |